BDO Wealth Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

BDO Wealth Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-46	Closed	-$4K	–	1174
2022 Q2	$4K	Hold	46	–	–	﹤0.01%	834
2022 Q1	$5K	Hold	46	–	–	﹤0.01%	839
2021 Q4	$5K	Hold	46	–	–	﹤0.01%	841
2021 Q3	$5K	Hold	46	–	–	﹤0.01%	842
2021 Q2	$4K	Hold	46	–	–	﹤0.01%	924
2021 Q1	$4K	Hold	46	–	–	﹤0.01%	909
2020 Q4	$3K	Hold	46	–	–	﹤0.01%	743
2020 Q3	$4K	Buy	+46	New	+$3.17K	﹤0.01%	602
2020 Q1	–	Sell	-200	Closed	-$7K	–	857
2019 Q4	$7K	Hold	200	–	–	﹤0.01%	461
2019 Q3	$5K	Hold	200	–	–	﹤0.01%	515
2019 Q2	$5K	Hold	200	–	–	﹤0.01%	511
2019 Q1	$5K	Buy	+200	New	+$4.74K	﹤0.01%	483

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

BDO Wealth Advisors's HZNP Position: Q3 2022 in Review

BDO Wealth Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 46 shares — an estimated $4K sold.

BDO Wealth Advisors first reported a position in HZNP in Q1 2019 and held it in 12 quarters. The position peaked at $7K in Q4 2019. 530 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

BDO Wealth Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
BDO Wealth Advisors sold 46 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $4K.
BDO Wealth Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2019 and held it in 12 quarters.
BDO Wealth Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $7K in Q4 2019.
530 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on BDO Wealth Advisors's 13F filing for Q3 2022, filed 1 Nov 2022.